Literature DB >> 8893389

Sarcoidosis presenting as heart disease.

J E Nelson1, P A Kirschner, A S Teirstein.   

Abstract

It is unusual for sarcoidosis to present with isolated cardiac involvement. We report 3 patients in whom conduction disturbances preceded other clinical or radiographic evidence of sarcoidosis, in 2 cases by several years. The literature of sarcoidosis manifesting solely with cardiac disease is reviewed. Our report is intended to emphasize consideration of sarcoidosis in the diagnostic evaluation of cardiac disease without another obvious cause, particularly in young patients with conduction disturbances, arrhythmias, or cardiomyopathy. We suggest diagnostic strategies and a therapeutic approach.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893389

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  7 in total

Review 1.  Recommendations for 18F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations.

Authors:  Shinichiro Kumita; Keiichiro Yoshinaga; Masao Miyagawa; Mitsuru Momose; Keisuke Kiso; Tokuo Kasai; Masanao Naya
Journal:  J Nucl Cardiol       Date:  2019-08       Impact factor: 5.952

2.  A joint procedural position statement on imaging in cardiac sarcoidosis: from the Cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American Society of Nuclear Cardiology.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Patrizio Lancellotti; Fabien Hyafil; Ron Blankstein; Ronald G Schwartz; Wael A Jaber; Raymond Russell; Alessia Gimelli; François Rouzet; Marcus Hacker; Olivier Gheysens; Sven Plein; Edward J Miller; Sharmila Dorbala; Erwan Donal
Journal:  J Nucl Cardiol       Date:  2018-02       Impact factor: 5.952

3.  Outcomes of patients with definite and suspected isolated cardiac sarcoidosis treated with an implantable cardiac defibrillator.

Authors:  Jordana Kron; William Sauer; Gisela Mueller; Joseph Schuller; Frank Bogun; Sinan Sarsam; Lynda Rosenfeld; Teferi Y Mitiku; Joshua M Cooper; Davendra Mehta; Arnold J Greenspon; Matthew Ortman; David B Delurgio; Ravinder Valadri; Calambur Narasimhan; Nalla Swapna; Jagmeet P Singh; Stephan Danik; Steven M Markowitz; Adrian K Almquist; Andrew D Krahn; Luke G Wolfe; Shawn Feinstein; Kenneth A Ellenbogen; Thomas Crawford
Journal:  J Interv Card Electrophysiol       Date:  2015-02-13       Impact factor: 1.900

4.  Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM.

Authors:  Brett W Sperry; Timothy M Bateman; Esma A Akin; Paco E Bravo; Wengen Chen; Vasken Dilsizian; Fabien Hyafil; Yiu Ming Khor; Robert J H Miller; Riemer H J A Slart; Piotr Slomka; Hein Verberne; Edward J Miller; Chi Liu
Journal:  J Nucl Cardiol       Date:  2022-07-21       Impact factor: 3.872

5.  Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis.

Authors:  Osamu Manabe; Hiroshi Ohira; Keiichiro Yoshinaga; Takahiro Sato; Alisa Klaipetch; Noriko Oyama-Manabe; Yoichi M Ito; Ichizo Tsujino; Masaharu Nishimura; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-29       Impact factor: 9.236

6.  Prevalence of echocardiographic features suggesting cardiac sarcoidosis in patients with pacemaker or implantable cardiac defibrillator.

Authors:  Byung Joo Sun; Pil Hyung Lee; Hyung Oh Choi; Jung-Min Ahn; Jeong-Sook Seo; Dae-Hee Kim; Jong-Min Song; Kee Joon Choi; Duk-Hyun Kang; Jae-Kwan Song
Journal:  Korean Circ J       Date:  2011-06-30       Impact factor: 3.243

7.  Cardiac Sarcoidosis: Is it More Common in Men?

Authors:  Magdalena M Martusewicz-Boros; Piotr W Boros; Elżbieta Wiatr; Anna Kempisty; Dorota Piotrowska-Kownacka; Kazimierz Roszkowski-Śliż
Journal:  Lung       Date:  2015-09-28       Impact factor: 2.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.